The first case of lung carcinosarcoma harboring in-frame deletions at exon19 in the EGFR gene-Reference-Cited by-同舟云学术

The first case of lung carcinosarcoma harboring in-frame deletions at exon19 in the EGFR gene

Published:2013-09 Issue:3 Volume:81 Page:491-494
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Toyokawa Gouji,Takenoyama Mitsuhiro,Taguchi Kenichi,Arakaki Katsumi,Inamasu Eiko,Toyozawa Ryo,Kojo Miyako,Shiraishi Yoshimasa,Morodomi Yosuke,Takenaka Tomoyoshi,Hirai Fumihiko,Yamaguchi Masafumi,Seto Takashi,Leone Alvaro,Graziano Paolo,Ichinose Yukito

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference13 articles.

1. WHO classification of tumours. Pathology and genetics of tumours of the lung, pleura, thymus and heart;Travis,2004

2. EGFR and KRAS status of primary sarcomatoid carcinomas of the lung: implications for anti-EGFR treatment of a rare lung malignancy;Italiano;Int J Cancer,2009

3. Multiparametric molecular characterization of pulmonary sarcomatoid carcinoma reveals a nonrandom amplification of anaplastic lymphoma kinase (ALK) gene;Pelosi;Lung Cancer,2012

4. The value of biomarkers in patients with sarcomatoid carcinoma of the lung: molecular analysis of 33 cases;Jiang;Clin Lung Cancer,2012

5. Identification of EGFR mutations in lung sarcomatoid carcinoma;Leone;Int J Cancer,2011

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First case report of erlotinib plus ramucirumab treatment for lung carcinosarcoma with EGFR L858R mutation;Thoracic Cancer;2023-10-14

2. Neoadjuvant osimertinib and chemotherapy for stage IIIA primary pulmonary carcinosarcoma with EGFR 19DEL mutation: A case report;Frontiers in Oncology;2023-03-10

3. Molecular and expressional characterization of tumor heterogeneity in pulmonary carcinosarcoma;Molecular Carcinogenesis;2022-07-18

4. Carcinosarcoma and sarcomatoid carcinoma of the stomach;Medicine;2021-03-26

5. Lung Cancer;Practical Oncologic Molecular Pathology;2021